Page last updated: 2024-08-25

5-fluoropyrimidine and Local Neoplasm Recurrence

5-fluoropyrimidine has been researched along with Local Neoplasm Recurrence in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Duan, J; Jiang, Y; Liao, W; Lin, L; Pan, C; Su, Y; Sun, L; Zhang, J	1

Other Studies

1 other study(ies) available for 5-fluoropyrimidine and Local Neoplasm Recurrence

Article	Year
Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer. Molecular medicine reports, 2015, Volume: 12, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Female; Gene Expression Regulation, Neoplastic; GTPase-Activating Proteins; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prognosis; Pyrimidines; Retrospective Studies; Signal Transduction; Stomach Neoplasms; Survival Analysis; Tumor Burden; Tumor Suppressor Proteins	2015

Article

Year

Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer.

Molecular medicine reports, 2015, Volume: 12, Issue:4

Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Female; Gene Expression Regulation, Neoplastic; GTPase-Activating Proteins; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prognosis; Pyrimidines; Retrospective Studies; Signal Transduction; Stomach Neoplasms; Survival Analysis; Tumor Burden; Tumor Suppressor Proteins

2015